Posted On: 03/15/2015 10:20:41 PM
Post# of 30035
If Amarantus does a 20:1 RS, that would at least get us to a position to uplist, right? What would be the risk associated with that?
I understand the dynamics of uplisting as statistically a bad idea, but if the ratio were small enough and we got off the OTC, it would appear to be a win win.
Dunno....just looking for other opinions.
I understand the dynamics of uplisting as statistically a bad idea, but if the ratio were small enough and we got off the OTC, it would appear to be a win win.
Dunno....just looking for other opinions.
(0)
(0)
Scroll down for more posts ▼